The study will assess how efficiently activated charcoal will block absorption of tiotropium via the gastro intestinal track. Pharmacokinetics of tiotropium will be compared after orally administered tiotropium capsule with and without concomitant activated charcoal administration in healthy volunteers.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
20
Oral capsule 20 μg
Oral capsule 20 μg
Clinical Pharmacology Unit
Espoo, Finland
The pharmacokinetic parameter Area Under Curve (AUC)
Time frame: 24 hours
Peak concentration in plasma (Cmax) and time to reach peak concentration in plasma (tmax)
Time frame: (0 hours) and at 15, 30 and 45 minutes, and 1,1.5, 2, 3, 3.5, 4, 4.5, 5, 6, 8, 12 and 24 hours after the administration
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.